nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Nasal congestion—Cisplatin—testicular cancer	0.00867	0.00867	CcSEcCtD
Dimenhydrinate—Tremor—Chlorambucil—testicular cancer	0.00781	0.00781	CcSEcCtD
Dimenhydrinate—Agitation—Chlorambucil—testicular cancer	0.00766	0.00766	CcSEcCtD
Dimenhydrinate—Irritability—Cisplatin—testicular cancer	0.00754	0.00754	CcSEcCtD
Dimenhydrinate—Neuritis—Epirubicin—testicular cancer	0.00748	0.00748	CcSEcCtD
Dimenhydrinate—Dysuria—Ifosfamide—testicular cancer	0.0074	0.0074	CcSEcCtD
Dimenhydrinate—Pollakiuria—Ifosfamide—testicular cancer	0.00731	0.00731	CcSEcCtD
Dimenhydrinate—Convulsion—Chlorambucil—testicular cancer	0.00722	0.00722	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Dactinomycin—testicular cancer	0.00719	0.00719	CcSEcCtD
Dimenhydrinate—Neuritis—Doxorubicin—testicular cancer	0.00692	0.00692	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Ifosfamide—testicular cancer	0.00692	0.00692	CcSEcCtD
Dimenhydrinate—Vertigo—Vinblastine—testicular cancer	0.00687	0.00687	CcSEcCtD
Dimenhydrinate—Confusional state—Chlorambucil—testicular cancer	0.00686	0.00686	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Chlorambucil—testicular cancer	0.00666	0.00666	CcSEcCtD
Dimenhydrinate—Chills—Bleomycin—testicular cancer	0.00665	0.00665	CcSEcCtD
Dimenhydrinate—Sweating increased—Cisplatin—testicular cancer	0.00665	0.00665	CcSEcCtD
Dimenhydrinate—Convulsion—Vinblastine—testicular cancer	0.00662	0.00662	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Ifosfamide—testicular cancer	0.00659	0.00659	CcSEcCtD
Dimenhydrinate—Anorexia—Chlorambucil—testicular cancer	0.00649	0.00649	CcSEcCtD
Dimenhydrinate—Chills—Dactinomycin—testicular cancer	0.0062	0.0062	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Vinblastine—testicular cancer	0.00611	0.00611	CcSEcCtD
Dimenhydrinate—Sweating increased—Etoposide—testicular cancer	0.00609	0.00609	CcSEcCtD
Dimenhydrinate—Dyspepsia—Chlorambucil—testicular cancer	0.00599	0.00599	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Cisplatin—testicular cancer	0.00596	0.00596	CcSEcCtD
Dimenhydrinate—Anorexia—Vinblastine—testicular cancer	0.00594	0.00594	CcSEcCtD
Dimenhydrinate—Decreased appetite—Chlorambucil—testicular cancer	0.00592	0.00592	CcSEcCtD
Dimenhydrinate—Tinnitus—Ifosfamide—testicular cancer	0.00591	0.00591	CcSEcCtD
Dimenhydrinate—Fatigue—Chlorambucil—testicular cancer	0.00587	0.00587	CcSEcCtD
Dimenhydrinate—Chills—Ifosfamide—testicular cancer	0.00569	0.00569	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Chlorambucil—testicular cancer	0.00561	0.00561	CcSEcCtD
Dimenhydrinate—Paraesthesia—Vinblastine—testicular cancer	0.0056	0.0056	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Etoposide—testicular cancer	0.00546	0.00546	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vinblastine—testicular cancer	0.00542	0.00542	CcSEcCtD
Dimenhydrinate—Urticaria—Chlorambucil—testicular cancer	0.00541	0.00541	CcSEcCtD
Dimenhydrinate—Constipation—Vinblastine—testicular cancer	0.00533	0.00533	CcSEcCtD
Dimenhydrinate—Confusional state—Bleomycin—testicular cancer	0.00531	0.00531	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Etoposide—testicular cancer	0.0052	0.0052	CcSEcCtD
Dimenhydrinate—Vision blurred—Ifosfamide—testicular cancer	0.0052	0.0052	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Bleomycin—testicular cancer	0.00516	0.00516	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Vinblastine—testicular cancer	0.00514	0.00514	CcSEcCtD
Dimenhydrinate—Tinnitus—Cisplatin—testicular cancer	0.00509	0.00509	CcSEcCtD
Dimenhydrinate—Agitation—Ifosfamide—testicular cancer	0.00507	0.00507	CcSEcCtD
Dimenhydrinate—Anorexia—Bleomycin—testicular cancer	0.00502	0.00502	CcSEcCtD
Dimenhydrinate—Vertigo—Ifosfamide—testicular cancer	0.00496	0.00496	CcSEcCtD
Dimenhydrinate—Photosensitivity—Methotrexate—testicular cancer	0.00493	0.00493	CcSEcCtD
Dimenhydrinate—Hypotension—Bleomycin—testicular cancer	0.00492	0.00492	CcSEcCtD
Dimenhydrinate—Asthenia—Chlorambucil—testicular cancer	0.00488	0.00488	CcSEcCtD
Dimenhydrinate—Palpitations—Ifosfamide—testicular cancer	0.00487	0.00487	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Dactinomycin—testicular cancer	0.00481	0.00481	CcSEcCtD
Dimenhydrinate—Convulsion—Ifosfamide—testicular cancer	0.00478	0.00478	CcSEcCtD
Dimenhydrinate—Paraesthesia—Bleomycin—testicular cancer	0.00473	0.00473	CcSEcCtD
Dimenhydrinate—Anorexia—Dactinomycin—testicular cancer	0.00468	0.00468	CcSEcCtD
Dimenhydrinate—Diarrhoea—Chlorambucil—testicular cancer	0.00466	0.00466	CcSEcCtD
Dimenhydrinate—Photosensitivity—Epirubicin—testicular cancer	0.00462	0.00462	CcSEcCtD
Dimenhydrinate—Decreased appetite—Bleomycin—testicular cancer	0.00458	0.00458	CcSEcCtD
Dimenhydrinate—Confusional state—Ifosfamide—testicular cancer	0.00454	0.00454	CcSEcCtD
Dimenhydrinate—Chills—Etoposide—testicular cancer	0.00449	0.00449	CcSEcCtD
Dimenhydrinate—Vision blurred—Cisplatin—testicular cancer	0.00448	0.00448	CcSEcCtD
Dimenhydrinate—Asthenia—Vinblastine—testicular cancer	0.00447	0.00447	CcSEcCtD
Dimenhydrinate—Tremor—Cisplatin—testicular cancer	0.00445	0.00445	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Ifosfamide—testicular cancer	0.00441	0.00441	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Ifosfamide—testicular cancer	0.00435	0.00435	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Bleomycin—testicular cancer	0.00434	0.00434	CcSEcCtD
Dimenhydrinate—Vomiting—Chlorambucil—testicular cancer	0.00433	0.00433	CcSEcCtD
Dimenhydrinate—Anorexia—Ifosfamide—testicular cancer	0.00429	0.00429	CcSEcCtD
Dimenhydrinate—Photosensitivity—Doxorubicin—testicular cancer	0.00427	0.00427	CcSEcCtD
Dimenhydrinate—Decreased appetite—Dactinomycin—testicular cancer	0.00427	0.00427	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vinblastine—testicular cancer	0.00427	0.00427	CcSEcCtD
Dimenhydrinate—Fatigue—Dactinomycin—testicular cancer	0.00424	0.00424	CcSEcCtD
Dimenhydrinate—Hypotension—Ifosfamide—testicular cancer	0.00421	0.00421	CcSEcCtD
Dimenhydrinate—Urticaria—Bleomycin—testicular cancer	0.00418	0.00418	CcSEcCtD
Dimenhydrinate—Irritability—Methotrexate—testicular cancer	0.00414	0.00414	CcSEcCtD
Dimenhydrinate—Dizziness—Vinblastine—testicular cancer	0.00412	0.00412	CcSEcCtD
Dimenhydrinate—Convulsion—Cisplatin—testicular cancer	0.00412	0.00412	CcSEcCtD
Dimenhydrinate—Diplopia—Epirubicin—testicular cancer	0.00405	0.00405	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Dactinomycin—testicular cancer	0.00405	0.00405	CcSEcCtD
Dimenhydrinate—Nausea—Chlorambucil—testicular cancer	0.00404	0.00404	CcSEcCtD
Dimenhydrinate—Paraesthesia—Ifosfamide—testicular cancer	0.00404	0.00404	CcSEcCtD
Dimenhydrinate—Somnolence—Ifosfamide—testicular cancer	0.004	0.004	CcSEcCtD
Dimenhydrinate—Vomiting—Vinblastine—testicular cancer	0.00397	0.00397	CcSEcCtD
Dimenhydrinate—Vertigo—Etoposide—testicular cancer	0.00391	0.00391	CcSEcCtD
Dimenhydrinate—Decreased appetite—Ifosfamide—testicular cancer	0.00391	0.00391	CcSEcCtD
Dimenhydrinate—Headache—Vinblastine—testicular cancer	0.00391	0.00391	CcSEcCtD
Dimenhydrinate—Fatigue—Ifosfamide—testicular cancer	0.00388	0.00388	CcSEcCtD
Dimenhydrinate—Constipation—Ifosfamide—testicular cancer	0.00385	0.00385	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Cisplatin—testicular cancer	0.0038	0.0038	CcSEcCtD
Dimenhydrinate—Tachycardia—Cisplatin—testicular cancer	0.00379	0.00379	CcSEcCtD
Dimenhydrinate—Asthenia—Bleomycin—testicular cancer	0.00378	0.00378	CcSEcCtD
Dimenhydrinate—Convulsion—Etoposide—testicular cancer	0.00377	0.00377	CcSEcCtD
Dimenhydrinate—Diplopia—Doxorubicin—testicular cancer	0.00375	0.00375	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Cisplatin—testicular cancer	0.00375	0.00375	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Ifosfamide—testicular cancer	0.00371	0.00371	CcSEcCtD
Dimenhydrinate—Nausea—Vinblastine—testicular cancer	0.0037	0.0037	CcSEcCtD
Dimenhydrinate—Anorexia—Cisplatin—testicular cancer	0.0037	0.0037	CcSEcCtD
Dimenhydrinate—Hypotension—Cisplatin—testicular cancer	0.00363	0.00363	CcSEcCtD
Dimenhydrinate—Confusional state—Etoposide—testicular cancer	0.00358	0.00358	CcSEcCtD
Dimenhydrinate—Urticaria—Ifosfamide—testicular cancer	0.00358	0.00358	CcSEcCtD
Dimenhydrinate—Asthenia—Dactinomycin—testicular cancer	0.00352	0.00352	CcSEcCtD
Dimenhydrinate—Dysuria—Methotrexate—testicular cancer	0.0035	0.0035	CcSEcCtD
Dimenhydrinate—Paraesthesia—Cisplatin—testicular cancer	0.00348	0.00348	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Etoposide—testicular cancer	0.00348	0.00348	CcSEcCtD
Dimenhydrinate—Tachycardia—Etoposide—testicular cancer	0.00347	0.00347	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Etoposide—testicular cancer	0.00344	0.00344	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Methotrexate—testicular cancer	0.00342	0.00342	CcSEcCtD
Dimenhydrinate—Anorexia—Etoposide—testicular cancer	0.00339	0.00339	CcSEcCtD
Dimenhydrinate—Decreased appetite—Cisplatin—testicular cancer	0.00337	0.00337	CcSEcCtD
Dimenhydrinate—Diarrhoea—Dactinomycin—testicular cancer	0.00336	0.00336	CcSEcCtD
Dimenhydrinate—Vomiting—Bleomycin—testicular cancer	0.00335	0.00335	CcSEcCtD
Dimenhydrinate—Drowsiness—Methotrexate—testicular cancer	0.00334	0.00334	CcSEcCtD
Dimenhydrinate—Hypotension—Etoposide—testicular cancer	0.00332	0.00332	CcSEcCtD
Dimenhydrinate—Rash—Bleomycin—testicular cancer	0.00332	0.00332	CcSEcCtD
Dimenhydrinate—Dermatitis—Bleomycin—testicular cancer	0.00332	0.00332	CcSEcCtD
Dimenhydrinate—Dysuria—Epirubicin—testicular cancer	0.00328	0.00328	CcSEcCtD
Dimenhydrinate—Pollakiuria—Epirubicin—testicular cancer	0.00324	0.00324	CcSEcCtD
Dimenhydrinate—Asthenia—Ifosfamide—testicular cancer	0.00323	0.00323	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Epirubicin—testicular cancer	0.0032	0.0032	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Cisplatin—testicular cancer	0.0032	0.0032	CcSEcCtD
Dimenhydrinate—Paraesthesia—Etoposide—testicular cancer	0.00319	0.00319	CcSEcCtD
Dimenhydrinate—Somnolence—Etoposide—testicular cancer	0.00316	0.00316	CcSEcCtD
Dimenhydrinate—Nausea—Bleomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Dimenhydrinate—Drowsiness—Epirubicin—testicular cancer	0.00312	0.00312	CcSEcCtD
Dimenhydrinate—Vomiting—Dactinomycin—testicular cancer	0.00312	0.00312	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Methotrexate—testicular cancer	0.00312	0.00312	CcSEcCtD
Dimenhydrinate—Rash—Dactinomycin—testicular cancer	0.0031	0.0031	CcSEcCtD
Dimenhydrinate—Decreased appetite—Etoposide—testicular cancer	0.00309	0.00309	CcSEcCtD
Dimenhydrinate—Diarrhoea—Ifosfamide—testicular cancer	0.00308	0.00308	CcSEcCtD
Dimenhydrinate—Fatigue—Etoposide—testicular cancer	0.00307	0.00307	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Epirubicin—testicular cancer	0.00306	0.00306	CcSEcCtD
Dimenhydrinate—Constipation—Etoposide—testicular cancer	0.00304	0.00304	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—testicular cancer	0.00303	0.00303	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—testicular cancer	0.003	0.003	CcSEcCtD
Dimenhydrinate—Dizziness—Ifosfamide—testicular cancer	0.00298	0.00298	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00296	0.00296	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Etoposide—testicular cancer	0.00293	0.00293	CcSEcCtD
Dimenhydrinate—Nausea—Dactinomycin—testicular cancer	0.00292	0.00292	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Epirubicin—testicular cancer	0.00292	0.00292	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—testicular cancer	0.00289	0.00289	CcSEcCtD
Dimenhydrinate—Vomiting—Ifosfamide—testicular cancer	0.00286	0.00286	CcSEcCtD
Dimenhydrinate—Rash—Ifosfamide—testicular cancer	0.00284	0.00284	CcSEcCtD
Dimenhydrinate—Dermatitis—Ifosfamide—testicular cancer	0.00284	0.00284	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00283	0.00283	CcSEcCtD
Dimenhydrinate—Urticaria—Etoposide—testicular cancer	0.00282	0.00282	CcSEcCtD
Dimenhydrinate—Tinnitus—Methotrexate—testicular cancer	0.00279	0.00279	CcSEcCtD
Dimenhydrinate—Asthenia—Cisplatin—testicular cancer	0.00278	0.00278	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Dimenhydrinate—Chills—Methotrexate—testicular cancer	0.00269	0.00269	CcSEcCtD
Dimenhydrinate—Nausea—Ifosfamide—testicular cancer	0.00267	0.00267	CcSEcCtD
Dimenhydrinate—Diarrhoea—Cisplatin—testicular cancer	0.00266	0.00266	CcSEcCtD
Dimenhydrinate—Tinnitus—Epirubicin—testicular cancer	0.00262	0.00262	CcSEcCtD
Dimenhydrinate—Asthenia—Etoposide—testicular cancer	0.00255	0.00255	CcSEcCtD
Dimenhydrinate—Chills—Epirubicin—testicular cancer	0.00252	0.00252	CcSEcCtD
Dimenhydrinate—Vomiting—Cisplatin—testicular cancer	0.00247	0.00247	CcSEcCtD
Dimenhydrinate—Vision blurred—Methotrexate—testicular cancer	0.00246	0.00246	CcSEcCtD
Dimenhydrinate—Rash—Cisplatin—testicular cancer	0.00245	0.00245	CcSEcCtD
Dimenhydrinate—Dermatitis—Cisplatin—testicular cancer	0.00244	0.00244	CcSEcCtD
Dimenhydrinate—Diarrhoea—Etoposide—testicular cancer	0.00243	0.00243	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Tension—Epirubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Dimenhydrinate—Nervousness—Epirubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Dimenhydrinate—Dizziness—Etoposide—testicular cancer	0.00235	0.00235	CcSEcCtD
Dimenhydrinate—Vertigo—Methotrexate—testicular cancer	0.00234	0.00234	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—testicular cancer	0.00233	0.00233	CcSEcCtD
Dimenhydrinate—Nausea—Cisplatin—testicular cancer	0.00231	0.00231	CcSEcCtD
Dimenhydrinate—Vision blurred—Epirubicin—testicular cancer	0.0023	0.0023	CcSEcCtD
Dimenhydrinate—Convulsion—Methotrexate—testicular cancer	0.00226	0.00226	CcSEcCtD
Dimenhydrinate—Vomiting—Etoposide—testicular cancer	0.00226	0.00226	CcSEcCtD
Dimenhydrinate—Agitation—Epirubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Dimenhydrinate—Rash—Etoposide—testicular cancer	0.00224	0.00224	CcSEcCtD
Dimenhydrinate—Dermatitis—Etoposide—testicular cancer	0.00224	0.00224	CcSEcCtD
Dimenhydrinate—Headache—Etoposide—testicular cancer	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Dimenhydrinate—Vertigo—Epirubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Dimenhydrinate—Palpitations—Epirubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Dimenhydrinate—Confusional state—Methotrexate—testicular cancer	0.00215	0.00215	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—testicular cancer	0.00213	0.00213	CcSEcCtD
Dimenhydrinate—Convulsion—Epirubicin—testicular cancer	0.00212	0.00212	CcSEcCtD
Dimenhydrinate—Nausea—Etoposide—testicular cancer	0.00211	0.00211	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Methotrexate—testicular cancer	0.00209	0.00209	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—testicular cancer	0.00208	0.00208	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Dimenhydrinate—Dry mouth—Epirubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Dimenhydrinate—Anorexia—Methotrexate—testicular cancer	0.00203	0.00203	CcSEcCtD
Dimenhydrinate—Confusional state—Epirubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—testicular cancer	0.002	0.002	CcSEcCtD
Dimenhydrinate—Hypotension—Methotrexate—testicular cancer	0.00199	0.00199	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—testicular cancer	0.00196	0.00196	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Epirubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Dimenhydrinate—Tachycardia—Epirubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Epirubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Dimenhydrinate—Insomnia—Methotrexate—testicular cancer	0.00193	0.00193	CcSEcCtD
Dimenhydrinate—Paraesthesia—Methotrexate—testicular cancer	0.00191	0.00191	CcSEcCtD
Dimenhydrinate—Anorexia—Epirubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Dimenhydrinate—Somnolence—Methotrexate—testicular cancer	0.00189	0.00189	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Dimenhydrinate—Dyspepsia—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Dimenhydrinate—Hypotension—Epirubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Dimenhydrinate—Decreased appetite—Methotrexate—testicular cancer	0.00185	0.00185	CcSEcCtD
Dimenhydrinate—Fatigue—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Dimenhydrinate—Insomnia—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Dimenhydrinate—Paraesthesia—Epirubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Dimenhydrinate—Somnolence—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—testicular cancer	0.00176	0.00176	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Dimenhydrinate—Dyspepsia—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Dimenhydrinate—Decreased appetite—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Dimenhydrinate—Fatigue—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Dimenhydrinate—Constipation—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Dimenhydrinate—Urticaria—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Dimenhydrinate—Urticaria—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Dimenhydrinate—Asthenia—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Dimenhydrinate—Diarrhoea—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Dimenhydrinate—Asthenia—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Dimenhydrinate—Dizziness—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Dimenhydrinate—Diarrhoea—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Dimenhydrinate—Vomiting—Methotrexate—testicular cancer	0.00135	0.00135	CcSEcCtD
Dimenhydrinate—Rash—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Dimenhydrinate—Dermatitis—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Dimenhydrinate—Headache—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Dimenhydrinate—Dizziness—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Dimenhydrinate—Vomiting—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Dimenhydrinate—Nausea—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Dimenhydrinate—Rash—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Dimenhydrinate—Dermatitis—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Dimenhydrinate—Headache—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Dimenhydrinate—Nausea—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Dimenhydrinate—Nausea—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
